Cargando…

A proof-of-concept study on the use of a fluorescein-based (18)F-tracer for pretargeted PET

BACKGROUND: Pretargeted immuno-PET tumor imaging has emerged as a valuable diagnostic strategy that combines the high specificity of antibody-antigen interaction with the high signal and image resolution offered by short-lived PET isotopes, while reducing the irradiation dose caused by traditional (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helbert, Hugo, Ploeg, Emily M., Samplonius, Douwe F., Blok, Simon N., Antunes, Ines F., Böhmer, Verena I., Luurtsema, Gert, Dierckx, Rudi A. J. O., Feringa, Ben L., Elsinga, Philip H., Szymanski, Wiktor, Helfrich, Wijnand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894538/ https://www.ncbi.nlm.nih.gov/pubmed/35239034 http://dx.doi.org/10.1186/s41181-022-00155-2

Ejemplares similares

Modular Medical Imaging Agents Based on Azide–Alkyne Huisgen Cycloadditions: Synthesis and Pre‐Clinical Evaluation of (18)F‐Labeled PSMA‐Tracers for Prostate Cancer Imaging
por: Böhmer, Verena I., et al.
Publicado: (2020)

A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members
por: He, Yuan, et al.
Publicado: (2017)

Ultrafast Photoclick Reaction for Selective (18)F-Positron Emission Tomography Tracer Synthesis in Flow
por: Fu, Youxin, et al.
Publicado: (2021)

Synthesis of Substituted Benzaldehydes via a Two-Step, One-Pot Reduction/Cross-Coupling Procedure
por: Heijnen, Dorus, et al.
Publicado: (2019)

Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα “don’t eat me” immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation
por: Hendriks, Mark A. J. M., et al.
Publicado: (2020)

Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis
por: Hendriks, Mark A.J.M., et al.
Publicado: (2021)

Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells
por: Britsch, Isabel, et al.
Publicado: (2023)

Test–Retest Repeatability of [(18)F]MC225-PET in Rodents: A Tracer for Imaging of P-gp Function
por: García-Varela, Lara, et al.
Publicado: (2020)

A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer
por: Ploeg, Emily Maria, et al.
Publicado: (2023)

Pretargeting of internalizing trastuzumab and cetuximab with a (18)F-tetrazine tracer in xenograft models
por: Keinänen, Outi, et al.
Publicado: (2017)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023)

Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction
por: Hendriks, Djoke, et al.
Publicado: (2016)

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
por: Koopmans, Iris, et al.
Publicado: (2018)

Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells
por: Bremer, Edwin, et al.
Publicado: (2008)

Head-to-head comparison of (R)-[(11)C]verapamil and [(18)F]MC225 in non-human primates, tracers for measuring P-glycoprotein function
por: García-Varela, Lara, et al.
Publicado: (2021)

Hybrid Imaging Agents for Pretargeting Applications Based on Fusarinine C—Proof of Concept
por: Summer, Dominik, et al.
Publicado: (2020)

Hunting for the high‐affinity state of G‐protein‐coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging
por: Shalgunov, Vladimir, et al.
Publicado: (2018)

Therapeutic Applications of Pretargeting
por: Verhoeven, Marjolein, et al.
Publicado: (2019)

Molecular Motors in Aqueous Environment
por: Lubbe, Anouk S., et al.
Publicado: (2018)

The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells
por: Wiersma, Valerie R, et al.
Publicado: (2012)

A new approach to produce [(18)F]MC225 via one-step synthesis, a PET radiotracer for measuring P-gp function
por: Garcia-Varela, Lara, et al.
Publicado: (2021)

Pretargeted Molecular Imaging and Radioimmunotherapy
por: Goldenberg, David M., et al.
Publicado: (2012)

Improvement of Radioimmunotherapy Using Pretargeting
por: Frampas, Eric, et al.
Publicado: (2013)

Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma.
por: Magnani, P., et al.
Publicado: (1996)

A Photocleavable Contrast Agent for Light-Responsive MRI
por: Reeßing, Friederike, et al.
Publicado: (2020)

The Development of a Smart Magnetic Resonance Imaging and Chemical Exchange Saturation Transfer Contrast Agent for the Imaging of Sulfatase Activity
por: Welleman, Ilse M., et al.
Publicado: (2023)

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
por: Kraeber–Bodéré, F., et al.
Publicado: (2009)

Clearing and Masking Agents in Pretargeting Strategies
por: Staudt, Markus, et al.
Publicado: (2023)

Galectin-9 Activates and Expands Human T-Helper 1 Cells
por: Gooden, Marloes J. M., et al.
Publicado: (2013)

Automated Detection of Vascular Leakage in Fluorescein Angiography – A Proof of Concept
por: Young, LeAnne H., et al.
Publicado: (2022)

Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept
por: Rondon, Aurélie, et al.
Publicado: (2019)

Synthesis and evaluation in rats of homologous series of [(18)F]-labeled dopamine D(2/3) receptor agonists based on the 2-aminomethylchroman scaffold as potential PET tracers
por: Shalgunov, Vladimir, et al.
Publicado: (2015)

Pharmacokinetic Modeling of [(11)C]GSK-189254, PET Tracer Targeting H(3) Receptors, in Rat Brain
por: Ghazanfari, Nafiseh, et al.
Publicado: (2022)

In Vivo Induction of P-Glycoprotein Function can be Measured with [(18)F]MC225 and PET
por: García-Varela, Lara, et al.
Publicado: (2021)

Pretargeting for imaging and therapy in oncological nuclear medicine
por: Bailly, Clément, et al.
Publicado: (2017)

Pretargeted imaging beyond the blood–brain barrier
por: Shalgunov, Vladimir, et al.
Publicado: (2022)

Automated synthesis, preclinical toxicity, and radiation dosimetry of [(18)F]MC225 for clinical use: a tracer for measuring P-glycoprotein function at the blood-brain barrier
por: Toyohara, Jun, et al.
Publicado: (2020)

Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels–Alder Reaction and Key Factors in the Pretargeted Synthetic Design
por: Qiu, Lin, et al.
Publicado: (2019)

Evaluation of Tracer Kinetic Models for Analysis of [(18)F]FDDNP Studies
por: Yaqub, Maqsood, et al.
Publicado: (2009)

Biotinylated magnetic nanoparticles for pretargeting: synthesis and characterization study
por: Chauhan, Ram Prakash, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_aqkqvenha82ss0l54qbvkg7snn